We're taking a nearly 300% profit on a hot drug stock — adhering to an investing rule to live by

• Financial Times - World

  Fee rule changes to boost UK investment trusts

  Exemption from cost disclosures to make the products more attractive to both institutions and customers
  
  9 hours ago - United Kingdom
• The Guardian - World

  Harris calls Trump the ‘architect’ of abortion crisis for overturning Roe v Wade – US politics live

  Vice-president highlights case of Amber Thurman, who died in Georgia after being denied timely medical care due strict abortion ban. Kamala Harris will be in Georgia today and is expected to ...
  
  13 minutes ago - Abortion
• Financial Times - Business

  Mercedes-Benz shares fall after profit warning

  German carmaker lowers full-year outlook on weakness in Chinese demand
  
  12 hours ago
• Yahoo News - World

  Nearly 500 migrants rescued off the Canary Islands

  9 hours ago
• Financial Times - Business

  Murdoch’s REA ups offer for Rightmove to nearly £5.9bn

  Revised offer for property listings group follows dismissal of initial approach as ‘opportunistic’
  
  3 hours ago
• The Wall Street Journal - Business

  FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue

  FedEx’s results were dragged down by weaker-than-expected demand, particularly in the U.S. domestic package market.
  
  23 hours ago
• The Hill - Politics

  Harris and Oprah hold star-studded event to discuss hot-button issues

  Vice President Harris and media mogul Oprah Winfrey sat down for an event in Michigan to discuss issues ranging from immigration to the economy, reproductive rights and gun violence prevention. The ...
  
  18 hours ago
• ABC News - Top stories

  LIVE: ABC News Live

  24/7 coverage of breaking news and live events
  
  4 hours ago
• Financial Times - World

  Is it time to invest in the UK’s green transition again?

  Labour’s ambitious environmental agenda has lifted the outlook for clean energy groups and investment vehicles
  
  17 hours ago
• The New York Times - Health

  F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

  The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
  
  5 hours ago

More from CNBC

• CNBC - Business

  Qualcomm recently approached Intel about a possible takeover

  If Qualcomm were to acquire Intel, it would be one of the largest technology deals on record, but would first invite hefty regulatory scrutiny.
  
  18 minutes ago
• CNBC - Business

  Apple iPhone 16, Apple Watch Series 10 and AirPods 4 debut around the world

  Apple greeted customers at its stores around the world on Friday, for the debuts of the iPhone 16, Apple Watch Series 10 and AirPods 4.
  
  6 hours ago - Apple
• CNBC - Business

  Constellation Energy to restart Three Mile Island nuclear plant, sell the power to Microsoft for AI

  Constellation described the agreement with Microsoft as the largest power purchase agreement that the nuclear plant operator has ever signed.
  
  30 minutes ago - Microsoft
• CNBC - Business

  Fed Governor Waller says inflation softening faster than he expected put him in half-point-cut camp

  Waller told CNBC that the data is showing core inflation in the Fed's preferred measure is running below 1.8%
  
  2 hours ago - Federal Reserve
• CNBC - Business

  FTC sues drug middlemen for allegedly inflating insulin prices

  The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
  
  1 hour ago